Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity.

Advances in experimental medicine and biology - 1 Jan 2000

van Kuilenburg A B, Haasjes J, Van Lenthe H, Zoetekouw L, Waterham H R, Vreken P, van Gennip A H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Dihydrouracil Dehydrogenase (NADP)
Share to Fluorouracil
Share to Heterozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukocytes, Mononuclear

Share to Oxidoreductases

Source

Identifiers

PMID: 11783494
DOI: 10.1007/0-306-46843-3_49

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity.PMID 11783494Read ↗

Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil.Semantic proximity Read ↗

Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy.Semantic proximity Read ↗

Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration.Semantic proximity Read ↗

Biochemical and clinical pharmacology of 5-fluorouracil.Semantic proximity Read ↗

Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy.Semantic proximity Read ↗

Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.Semantic proximity Read ↗

5-Fluorouracil: mechanisms of action and clinical strategiesSemantic proximity Read ↗

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeSemantic proximity Read ↗

The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil.Semantic proximity Read ↗

Multiple organ failure due to 5-fluorouracil chemotherapy in a patient with a rare dihydropyrimidine dehydrogenase gene variant.Semantic proximity Read ↗

Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiencySemantic proximity Read ↗

Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.